Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 2,588 shares at $73.90 ($191K) on 2011-02-14, disclosed to the SEC on 2011-02-15.
Open-market sale of $191k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |